The recent decision by the National Health Service (SNS) to centralize medication purchases has raised concerns among pharmaceutical associations. They fear that the obligation for hospitals to purchase 80% of their products through specific channels will harm competition and the quality of care. Organizations are calling for exception mechanisms to ensure supply in case of emergencies and for dialogue with the SNS to revise this measure.